In a significant move, the US Food and Drug Administration (FDA) has escalated a recall of cough drops sold across the United States, citing elevated health risks. This action comes as allergy season approaches, prompting officials to advise customers to meticulously inspect their cabinets and pantries for affected products.
Recall Details and FDA Classification
The recall, initially announced on March 20, 2026, by China-based company Xiamen Kang Zhongyuan Biotechnology Co., Ltd., was upgraded to a Class II recall by the FDA as of April 10, 2026. A Class II classification indicates that ingestion of the recalled cough drops could lead to temporary or medically reversible adverse health consequences, though the specific risks were not detailed in the announcement.
The decision to initiate the recall stemmed from an inspection of the manufacturing facility conducted in August 2025, which raised concerns about product safety. While the FDA has not provided additional specifics on the inspection findings, the escalation underscores the seriousness of the potential hazards.
Affected Brands and Products
Multiple brands and products have been implicated in this widespread recall, impacting various flavors and pack sizes. Consumers should be vigilant for the following items, which are part of the recall list:
- Exchange Select: Menthol-Cough Suppressant Oral Anesthetic Cough Drops Honey Lemon Flavor, 30-count bag
- Exchange Select: Menthol-Cough Suppressant Oral Anesthetic Cough Drops Menthol Flavor, 30-count bag
- Caring Mill: Menthol Cough Suppressant Oral Anesthetic Cough Drops Cherry Flavor, 90-count bag
- Discount Drug Mart Food Market: Menthol- Cough Suppressant Anesthetic Cough Drops Honey Lemon Flavor, 30-count bag
- Discount Drug Mart Food Market: Menthol -Cough Suppressant Anesthetic Cough Drops, 30-count bag
- MGC Health: Menthol- Cough Suppressant Oral Anesthetic Cough Drops Sugar Free Honey Lemon Flavor, 25-count bag
- MGC Health: Menthol- Cough Suppressant Oral Anesthetic Cough Drops Honey Lemon Flavor, 30-count bag
- MGC Health: Menthol- Cough Suppressant Oral Anesthetic Cough Drops Honey Lemon, 80-count bag
- QC Quality Choice: Menthol-Cough Suppressant Oral Anesthetic Cough Drops Sugar Free Black Cherry Flavor, 25-count bag
- QC Quality Choice: Menthol-Cough Suppressant Oral Anesthetic Cough Drops Cherry Flavor, 30-count bag
- QC Quality Choice: Menthol-Cough Suppressant Oral Anesthetic Cough Drops Sugar Free Honey Lemon Flavor, 25-count bag
- QC Quality Choice: Pectin Oral Demulcent Throat Soothing Drops Creamy Strawberry Flavor, 30-count bag
- QC Quality Choice: Menthol-Cough Suppressant Oral Anesthetic Cough Drops Honey Lemon Flavor, 30-count bag
- QC Quality Choice: Menthol-Cough Suppressant Oral Anesthetic Cough Drops Menthol Flavor, 30-count bag
- QC Quality Choice: Menthol-Cough Suppressant Oral Anesthetic Cough Drops Vanilla Honey Flavor, 30-count bag
For precise identification, consumers are directed to the FDA's official website, where a comprehensive list of lot codes and expiration dates for each product is available. Although no formal press release was issued for this recall, standard protocol recommends that individuals discard the affected cough drops or return them to the point of purchase for a full refund.
Broader Context of Recalls
This cough drop recall adds to a series of consumer safety concerns during allergy season. In a related development, the FDA has also announced a separate recall involving more than 3.1 million bottles of eye drops. These products, manufactured by California-based K.C. Pharmaceuticals and sold under brands such as Dry Eye Relief Eye Drops and Sterile Eye Drops Redness Lubricant, are being pulled from shelves due to potential sterility issues.
The eye drop recall affects eight brands, with the largest lot comprising over 1 million bottles distributed at major retailers like Rite Aid, H-E-B, and Harris Teeter. Consumers can identify affected eye drops by checking the Universal Product Code or National Drug Code numbers, typically located near the barcode on the packaging.
As health authorities intensify scrutiny, these recalls highlight ongoing challenges in ensuring product safety across the pharmaceutical and consumer goods sectors. The public is encouraged to stay informed through official channels and take prompt action to mitigate health risks.
